On a Roll: FDA Calls Sage's Depression Drug a Breakthrough Post author:Sam Post published:February 6, 2018 Post category:BioPharma This is the second Breakthrough Therapy designation granted to Sage since 2016. Source: BioSpace You Might Also Like Merck KGaA in Deep Talks to Sell Biosimilars Unit March 8, 2017 Sales Of Olainfarm In August Increase By 19% September 14, 2017 3 Biotechs Bloodied Celgene Could Take Out October 30, 2017
